Marshall Wace’s CVS Health CVS Stock Holding History

Marshall Wace’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-400	Closed	-$30.2K	–	3049
2025 Q3	$30.2K	Buy	+400	New	+$27.4K	﹤0.01%	2763
2023 Q3	–	Sell	-29,400	Closed	-$2.03M	–	2278
2023 Q2	$2.03M	Sell	29,400 -271,500	-90%	-$19.3M	﹤0.01%	1402
2023 Q1	$22.4M	Buy	300,900 +232,000	+337%	+$19.5M	0.05%	432
2022 Q4	$6.42M	Buy	68,900 +36,300	+111%	+$3.5M	0.01%	1035
2022 Q3	$3.11M	Buy	+32,600	New	+$3.23M	0.01%	1716
2021 Q4	–	Sell	-1,400	Closed	-$118K	–	3927
2021 Q3	$118K	Buy	+1,400	New	+$117K	﹤0.01%	2872
2021 Q2	–	Sell	-3,400	Closed	-$256K	–	2722
2021 Q1	$256K	Buy	+3,400	New	+$248K	﹤0.01%	2174

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Marshall Wace's CVS Position: Q1 2026 in Review

Marshall Wace increased its CVS Health (CVS) stake by 5,129% in Q1 2026, buying an estimated $61M and bringing the position to 807,534 shares worth $58M. The position accounts for 0.06% of the portfolio, ranked #314.

Marshall Wace first reported a position in CVS in Q2 2014 and has held it in 44 quarters since. The position peaked at $383M in Q4 2023. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Marshall Wace held 807,534 shares of CVS Health worth $58M as of Q1 2026.
Marshall Wace bought 792,090 CVS Health shares in Q1 2026, an estimated $61M.
CVS Health made up 0.06% of Marshall Wace's portfolio in Q1 2026, its #314 holding.
Marshall Wace first reported a position in CVS Health in Q2 2014 and has held it in 44 quarters since.
Marshall Wace's CVS Health position peaked at $383M in Q4 2023.
1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.